Dr. Stoddard

Marcus F. Stoddard, M.D., F.A.C.C., F.A.H.A.

Professor of Medicine

Clinical Chief, Cardiovascular Medicine

Tel.: (502) 852-7959/sec. 1835 (ACB)

E-mail: mfstod01@louisville.edu

Dr. Stoddard is the Clinical Chief, Cardiovascular Medicine, Director of Noninvasive Cardiology at the University of Louisville and Director of Echocardiography at the VAMC Center in Louisville, Kentucky.  He is board certified in Cardiovascular Medicine, Echocardiography, Nuclear Cardiology and Cardiac CT.  He is a nationally recognized investigator in the area of Echocardiography.  He has published over 200 manuscripts and abstracts in leading cardiology journals.  His areas of research include determinants of thrombus formation and embolization in atrial fibrillation, determinants of left atrial appendage function, echocardiographic assessment of diastolic function, transesophageal echocardiography (TEE) applications (aortic and mitral stenosis, pharmacologic stress testing and flow reserve) and stress echocardiography.  He has been the recipient of several AHA grant awards. He has served on the steering committee of multicenter trials (e.g., The Assessment of Cardioversion Utilizing Transesophageal Echocardiography-ACUTE).  He is the principal investigator in several multicenter trials, including  Warfarin versus Aspirin in Reduced Ejection Fraction (WARCEF), and ARISTOTLE.  He has served on the editorial board of the American Heart Journal and presently is a journal reviewer for several prestigious journals, such as Circulation, the Journal of the American College of Cardiology, the American Journal of Cardiology, the American Heart Journal, Journal of the American Society of Echocardiography, Chest and Mayo Clinic Proceedings.  He is recognized nationally for his teaching skills and instructs annual echocardiographic and TEE courses in conjunction with the ACCC the AHA, and the American Society of Echocardiography.  He is the Chair of the National Board of Echocardiography Committee for the Echocardiographic Board Examination.  He has served on numerous committees of the American Heart Association and American Society of Echocardiography.

Selected Publications:

•  Stoddard MF, Dawn B, Singh P.  Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 145(4):676-682, 2003.
•  Leesar MA, Stoddard MF, Xuan YT, Tang XL, Bolli R.  Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans.  J Am Coll Cardiol 42 (3): 437-45, 2003.
•  Hoque A, Maaieh M, Longaker R, Stoddard MF.  Exercise  Echocardiography and Thallium-201 Single-Photon Emission Computed Tomography Stress Test in Long-term Prognosis of Mortality and Specific Cardiac Events. J Am Soc Echocardiogr 15(11):1326-34, 2002.
• Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW,      Black IW, Davidoff R,        Erbel R, Halperin JL, Orsinelli DA, Porter TR, Stoddard MF.  The ACUTE Steering and   Publications Committee for the ACUTE Investigators. Use of transesophageal         echocardiography to guide cardioversion of patients with atrial fibrillation.  N Engl J Med 344 (19): 1411-20, 2001.
• Stoddard MF, Wagner SC, Ikram S. Longaker RA, Prince CR.  Effects of nifedipine and nitroglycerin on left ventricular systolic dysfunction and impaired diastolic filling after exercise-induced ischemia in humans. J Am Coll Cardiol 28(4) 915-923, 1996.